Sartorius AG is a leading international partner to biopharmaceutical research and industry. The company supports biotech scientists and engineers worldwide in the development and manufacture of drugs - from the initial idea through to production. With sales of around 3.4 billion euros in 2023 and over 14,600 employees at more than 60 locations worldwide, Sartorius is helping to give more people access to better medicines.
Sartorius, a leading company with over 150 years of experience, offers a wide range of solutions for laboratories, including microbiology, lab filtration, pipettes and ultrapure water technology. The company is particularly well known for its balances, which have been a core product since Sartorius was founded. Today, Sartorius presents itself as an innovation leader with modular and state-of-the-art equipment that is used in various areas of research, analysis and production.
The Cubis II balance from Sartorius represents the latest technology in laboratory technology. This premium model impresses with its modular design, which makes it possible to adapt the balance exactly to the customer's requirements. Different displays, automatic or manual draft shield options and special features such as an ionizer make the Cubis II a versatile instrument. In addition, the balance offers an integrated app store and the option of programming customer-specific workflows directly on the balance. This ensures maximum efficiency and flexibility in laboratory operation.
Sartorius attaches great importance to sustainability and digital innovation. Operating manuals and other materials are increasingly provided digitally, significantly reducing paper consumption. The Cubis II and other models are designed to connect directly to LIMS systems or computers without the need for additional software licenses. These environmentally friendly and cost-effective solutions help to make everyday laboratory work easier and more sustainable.